Blog

Step therapy exceptions: the reasons that win and how to document each

Required to fail a cheaper drug first? A checklist of common exception grounds and the chart evidence behind each, plus where plan and state rules differ.

Step therapy asks you to start with a cheaper drug and move to the one your doctor prescribed only if the first one fails. Insurers and pharmacy benefit managers say it keeps costs down and steers people toward well-established treatments. Patients and many physicians say it can delay effective care and force people to repeat treatments that failed years ago. Both descriptions can be true in different cases, and both are the background to a practical question: if your plan requires a step you believe is wrong for you, what makes an exception request succeed?

The answer is nearly always documentation. A request that says "my doctor wants me on this drug" loses to one that says "the patient took the preferred drug from March to June at the maximum dose, stopped it because of a documented reaction, and the chart note is attached." This checklist sorts the usual grounds for an exception and names the evidence that supports each one.

First: find the rule that applies to you

Step therapy exceptions are governed by a mix of sources, and which one controls depends on the kind of plan you have. Before gathering anything, find out which rules apply, because they affect timelines and what the plan must accept.

  • [ ] The plan's own policy. Plans publish step therapy criteria, often in the formulary or a drug policy document, naming which drugs require a step, which drugs count as the step and how long the trial must last. Ask the plan for the specific criteria for your drug.
  • [ ] Your plan type. Individual and fully insured group plans are generally regulated by the state. Self-funded employer plans are generally governed by federal law and are typically outside state insurance mandates (see self-funded plan and ERISA). Medicare Part D plans follow federal exception rules. The post Is my plan ERISA or state-regulated? Five clues and why it changes my appeal shows how to tell which you have.
  • [ ] Your state's law, if it applies. A number of states have step therapy laws that require plans to have an exception process, often listing grounds for an exception and setting response times. They vary in scope and detail. Your state insurance department's website is the place to check the current rule, and a navigator or the department can tell you whether it reaches your plan.
  • [ ] Medicare Part D rules, if you have Part D. For drugs, Part D treats a step therapy requirement as a utilization management restriction that can be waived through an exception. The step-by-step path is in Part D coverage determination and exception: the step order that works.

The reason for this first step: a letter citing the wrong source of authority wastes a week. A letter that quotes the plan's own criteria and shows that you meet an exception ground does not.

The grounds, one at a time

Exception grounds written into state laws and plan policies differ in wording, but they tend to cluster in the same five places. For each, the evidence list is what the chart should contain.

Ground 1: You already tried the required drug (or a similar one) and it did not work

This is the strongest and the most documentable ground. The reason it works: the step requirement exists to make you try the cheaper drug, and you already have.

Evidence checklist:

  • [ ] Name of the drug, strength, dose and dates started and stopped
  • [ ] Pharmacy fill history that corroborates the dates
  • [ ] A clinician note describing the result: symptoms, test results or measurements before and after
  • [ ] If the trial was under a previous insurer, a note that says so, since many plans accept prior trials from other coverage, though the plan's policy states whether yours does
  • [ ] Why the trial counts as an adequate trial: enough dose and enough time for the drug to work

If the trial was short because you could not tolerate it, move to Ground 5.

Ground 2: The required drug is contraindicated

A contraindication means taking the drug would be unsafe for you. The reason it works: a plan cannot reasonably require a step that carries a known risk of harm.

Evidence checklist:

  • [ ] The specific reason: an allergy, a medical condition such as kidney or liver impairment, pregnancy, or a dangerous interaction with a drug you must keep taking
  • [ ] The current medication list, with doses
  • [ ] Relevant lab values or diagnoses with dates
  • [ ] The prescribing information or a clinical reference the doctor relies on for the contraindication, if the doctor is willing to cite it

Ground 3: The required drug is expected to be ineffective for you

The reason it works: the step is meant to find a treatment that works, and where it is clear in advance it will not, requiring it only adds delay.

Evidence checklist:

  • [ ] A clinical explanation tied to your history: a genetic marker, the severity or stage of disease, or a previous failure of a drug in the same class
  • [ ] Reference to a published clinical guideline or standard of care that supports starting with the requested drug in your situation, if one applies
  • [ ] The prescriber's statement that, based on your case, the step is unlikely to produce a benefit

This ground depends on the doctor's reasoning more than on records, so it is usually weaker than Ground 1 unless the clinical logic is specific.

Ground 4: You are stable on the requested drug and a switch carries risk

This ground comes up for people who changed insurers or whose plan added a step requirement after they started treatment. The reason it works: the step logic assumes a patient who has not yet started the drug, and someone doing well on it has already succeeded.

Evidence checklist:

  • [ ] Start date and duration of treatment on the requested drug
  • [ ] Documentation that you are stable: control of symptoms, steady test results, no hospital visits since starting
  • [ ] A clinical explanation of the risk of destabilizing, such as relapse, withdrawal or loss of function
  • [ ] History of failed switches, if any
  • [ ] Whether your plan has a continuity-of-care or transition provision, which may cover a supply while the exception is decided

Many plans and some state laws treat stability on a drug as a basis for an exception, but not all do. This is where the plan's own criteria matter.

Ground 5: Side effects or an adverse reaction to the required drug

The reason it works: intolerance is a failure of the step, even if the drug itself did not "fail" in the sense of not working.

Evidence checklist:

  • [ ] A description of the reaction, with dates and severity
  • [ ] Whether you needed treatment, an emergency visit or a hospital stay because of it
  • [ ] Whether lowering the dose or changing the timing was tried, and the result
  • [ ] The clinician's note that the drug was stopped because of the reaction

Other grounds worth checking

  • Delay would cause harm. If waiting through a step could lead to serious harm, say so and ask for an expedited review. The plan's expedited timeline is shorter, and the prescriber is the one who attests to the urgency.
  • The step drug is not available or not appropriate for another reason, such as a dosage form you cannot take or a supply problem.

The evidence table, side by side

Ground What the chart should show Who usually supplies it
Tried and failed Drug, dose, dates, outcome Prescriber's notes and pharmacy fill history
Contraindicated Allergy, condition or interaction, with dates Prescriber, plus allergy or lab records
Expected to be ineffective Clinical reasoning tied to your case Prescriber, with a guideline reference if applicable
Stable on the current drug Duration, control of disease, risk of switching Prescriber's notes and your own symptom log
Side effects Reaction, treatment needed, dose change attempts Prescriber and urgent care or hospital records if involved

A worked example with invented details

Say Jordan, 44, takes a prescribed medication for a chronic condition. A new plan year begins, and the plan's policy says the drug now requires a trial of two cheaper drugs first. Jordan has been on the drug for 18 months, with control of the condition. Before it, Jordan took one of the two required drugs for four months at the usual dose and stopped because of a reaction that required a doctor visit.

Jordan's checklist:

  1. Ask the plan for the step therapy criteria for the drug and the exception form.
  2. Identify the grounds: Ground 1 and 5 for the drug already tried and stopped, Ground 4 for stability on the current drug for the rest of the requirement.
  3. Ask the prescriber's office for the chart notes covering the reaction, the dates, the dose, and the 18 months of stable results.
  4. Pull the pharmacy fill history showing the four months of the earlier drug.
  5. Send the request with the prescriber's statement and attachments, and ask for an expedited review if a lapse in the current drug would risk relapse.

This is a hypothetical case, not a prediction. Whether a given plan accepts these grounds depends on its criteria and the rules that govern it.

Packaging the request

A strong request is short and organized:

  • [ ] A cover note naming the drug, the requirement you are asking to waive and the ground or grounds
  • [ ] The prescriber's statement, specific and dated (the doctor's side is covered in how my doctor can write a step therapy exception request that works)
  • [ ] Attachments in order: chart notes, medication history, test results, pharmacy record
  • [ ] A line asking the plan to say in writing which criteria it applied if it denies
  • [ ] A date by which you expect a response, based on the plan's published or legal time limit

Keep a copy of everything and write down the date and method of submission and any reference number.

If the exception is denied

Read the denial's stated reason. It often names a missing piece of evidence, which you can supply. Then:

  1. Internal appeal. File it within the deadline on the notice, with the missing evidence and a second letter from the prescriber that answers the reason.
  2. External review. For many plans, an independent reviewer can decide a denial based on medical necessity after the internal appeal (see external review explained: when an independent reviewer decides). For Medicare drug plans, the independent review step must be requested.
  3. Regulator. If the plan did not follow its own timelines or the state's rules, your state insurance department takes complaints about plans it regulates.

The general guide what to do when your plan will not cover a drug you need covers the other options, such as manufacturer assistance and generic alternatives, and the post what my doctor has to send for a drug prior authorization to succeed describes the prior authorization side of the same process.

What to ask the plan before you start

  • Which drugs count as the required steps for my drug, and for how long must I try each?
  • Do trials under a previous insurer count?
  • Is there an exception form, and does the prescriber have to submit it?
  • How many days does the plan have to answer a standard request and an expedited one?
  • If it denies, which document states the criteria it used?

Key takeaways

  • Step therapy exceptions succeed on documentation: dates, doses, outcomes and a specific clinical reason, not general statements.
  • The most common grounds are an earlier trial that failed, a contraindication, an expected lack of effect, stability on the current drug and side effects.
  • Find out which rules apply first: your plan's policy, your state's law if it reaches your plan, or Medicare Part D rules.
  • Ask for expedited review only when waiting could cause real harm, and expect the prescriber to attest to that.
  • If a request is denied, supply what the denial says was missing, then use the internal appeal, independent review and the regulator in that order.

Terms used in this guide

Related guides

Latest on this topic